James Foran
Professor of Medicine · Mayo Clinic College of Medicine and Science
Credentials: · · · ·
History
- 1993–1995
Medical Oncology
- 1990–1993
Internal Medicine
- 1986–1990
Research
Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML
New England Journal of Medicine · 2018 · 1,234 citations
Journal of Clinical Oncology · 2000 · First of 15 authors · Corresponding · 374 citations
Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network · 2019 · 359 citations
88 papers
85 papers
77 papers
76 papers
70 papers
70 papers
64 papers
63 papers
Grants
- 2005–2008
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $50.7K · University of Alabama at Birmingham
Clinical trials
- 2011–2022
Principal investigator · Completed · Phase 3
ECOG-ACRIN Cancer Research Group
- 2008–2009
Lenalidomide Therapy for Patients With Relapsed and/or Refractory, Peripheral T-Cell Lymphomas
Principal investigator · Terminated · Early phase 1
University of Alabama at Birmingham
- 2006–2007
Principal investigator · Terminated · Phase 2
BioCryst Pharmaceuticals
- 2004–2011
Study of Clofarabine & Cytosine Arabinoside Therapy for Older Adults With Acute Myeloid Leukemia
Principal investigator · Completed · Phase 1
University of Alabama at Birmingham